Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Most people who received two documented MMR doses are considered protected for life and do not need an extra shot, while adults born before 1957 are generally presumed immune from childhood exposure. A booster is most often recommended for those with only one dose who now face higher risk, including international travelers, college students, healthcare workers, household contacts of immunocompromised people, and anyone living in or traveling to an active outbreak area. People vaccinated between 1963 and 1968 may have received an inactivated version that offered weaker protection, so one additional MMR dose is advised for them, and a blood test for antibody titers can clarify uncertain cases. There are several important exceptions involving pregnancy, immune suppression, and unclear vaccination records, so see below to understand more before deciding.
If you are already dealing with fever, a spreading rash, red watery eyes, or a cough and you are unsure whether measles or something else is behind it, a free, instant, online symptom check can help you sort out likely causes in just a few minutes and show you which next step, urgent care, your primary doctor, or home monitoring, makes the most sense right now.
Last reviewed for medical accuracy: 10/01/2026
Measles is a highly contagious viral infection that can lead to serious complications, especially in young children and pregnant women. Thanks to widespread vaccination, measles cases have dropped dramatically. But immunity can wane over time, and certain situations call for an additional dose—or “booster”—of the MMR vaccine (measles, mumps, rubella). Below, we explain who may need a measles booster, why it matters, and how to decide if it’s right for you.
MMR boosters are very safe. Common, mild reactions include:
Serious reactions are extremely rare (fewer than 1 in a million):
If you have a history of severe allergy to gelatin, neomycin, or a previous MMR dose, tell your doctor before vaccination.
If you develop any symptoms that concern you—or if you suspect measles exposure—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) before deciding on next steps.
Always seek medical advice if you experience:
For non-urgent questions, your doctor can help you determine whether a booster is right for you, arrange blood testing, and schedule vaccination.
Protecting yourself with a measles booster not only keeps you healthy—it helps safeguard your community. Speak to a doctor to make the best choice for your situation.
(References)
* Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures. Lancet. 1977 Sep 17;2(8038):571-5. PMID: 71396.
* Mirchamsy H, Shafyi A, Mahinpour M, Nazari P. Age of measles immunization in tropics. Dev Biol Stand. 1978;41:191-4. PMID: 572788.
* Fel'dman EV, Kapustik LA, Belous TI, Bir'iak VN, Kuznetsova NK. [Effectiveness of the selective revaccination of schoolchildren against measles]. Zh Mikrobiol Epidemiol Immunobiol. 1985 Jun;(6):30-4. PMID: 2930972.
* Sokhin AA, Sliusar' LI, Popov VF, Noskov FS, Radomskaia FS. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels]. Zh Mikrobiol Epidemiol Immunobiol. 1983 Sep;(9):79-85. PMID: 6637278.
* Rafuse J. Catch-up immunization programs will eliminate measles threat for most schoolchildren. CMAJ. 1996 May 15;154(10):1567-8. PMID: 8625011; PMCID: PMC1487832.
* Marwick C. National effort to immunize adolescents begins. JAMA. 1996 Sep 11;276(10):766. PMID: 8769574.
* Durmaz R, Yakinci C, Köroğlu M, Tekerekoğlu MS. Immunological response to primary and secondary measles vaccination among school-age children in Malatya, Turkey. J Trop Pediatr. 1998 Apr;44(2):120. doi: 10.1093/tropej/44.2.120. PMID: 9604604.
* de Miguel AG. [Strategies of vaccination for adult population in Spain in the actuality]. An R Acad Nac Med (Madr). 2006;123(1):175-94. PMID: 17172219.
* Abramow-Newerly W, Litwińska B, Litwińska J, Sadowski W, Kańtoch M. Primary and secondary immune response to measles vaccine strain. Acta Microbiol Pol. 1980;29(3):227-32. PMID: 19852108.
* McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34. PMID: 23760231.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.